Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Infra Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
13 Sept 2024, 8:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tramadol HCl 50 mg Cap or Tab
Tab Glyceryl Trinitrate CR 2 point 6 mg
Tab Rosuvastatin 10 mg
Dexamethasone 0 point 5 mg Tab
Lorazepam 1mg Tab
6819255
GEM/2024/B/5322885
Two Packet Bid
Tramadol HCl 50 mg Cap or Tab,Tab Glyceryl Trinitrate CR 2 point 6 mg,Tab Rosuvastatin 10 mg,Dexame
15 days
Bihar; Gaya
Total value wise evaluation
BOQ
4 documents required · 4 mandatory
Exempted
14 Sept 2024
23 Aug 2024
13 Sept 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|
| 10293 | Tramadol HCl 50 mg Cap or Tab | 1,200 | No | GAYA | 10 | |
| 11119 | Tab Glyceryl Trinitrate CR 2 point 6 mg | 9,000 | No | GAYA | 10 | - |
| 128 | Tab Rosuvastatin 10 mg | 6,000 | No | GAYA | 10 | |
| 10308 | Dexamethasone 0 point 5 mg Tab | 1,800 | No | GAYA | 10 | |
| 12329 | Lorazepam 1mg Tab | 3,000 | No | GAYA | 10 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6819255.pdf
GEM_BID
item_specification_bid-10_2024-08-23-18-48-58_fe325b648f20b4f38d2a55aa3430b4cd.pdf
BOQ
boq_item_sample_file_2024-08-23-18-48-58_31f38f628bc0af1529985682a9988925.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .